Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Heterocyclic Compounds >  5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTER

5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTER

Basic information Safety Supplier Related

5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTER Basic information

Product Name:
5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTER
Synonyms:
  • 5-Bromo-1H-indazole-7-carboxylic acid methyl ester
  • Methyl 5-bromo-1H-indazole-7-carboxylate
  • 1H-Indazole-7-carboxylic acid, 5-broMo-, Methyl ester
  • 5-Bromo-7-(methoxycarbonyl)-1H-indazole
  • ethyl 5-broMo-1H-indazole-7-carboxylate
  • 5-Bromo-1H-indazole-7-carboxylic
  • 5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTER
CAS:
898747-24-5
MF:
C9H7BrN2O2
MW:
255.07
Mol File:
Mol File
More
Less

5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTER Chemical Properties

Boiling point:
395.9±22.0 °C(Predicted)
Density 
1.709±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
10.67±0.40(Predicted)
Appearance
Off-white to yellow Solid
InChI
InChI=1S/C9H7BrN2O2/c1-14-9(13)7-3-6(10)2-5-4-11-12-8(5)7/h2-4H,1H3,(H,11,12)
InChIKey
QQXHHJBRURQNLO-UHFFFAOYSA-N
SMILES
N1C2=C(C=C(Br)C=C2C(OC)=O)C=N1
More
Less

Safety Information

RIDADR 
2811
HazardClass 
6.1
PackingGroup 
HS Code 
2933998090
More
Less

5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTER Usage And Synthesis

Synthesis

206548-14-3

898747-24-5

Methyl 2-amino-5-bromo-3-methylbenzoate (19-S3, 10.9 g, 44.7 mmol) and potassium acetate (AcOK, 1.32 g, 13.41 mmol) were dissolved in dichloromethane (CH2Cl2, 50 mL) under nitrogen protection and cooled to 0 °C. Acetic anhydride (Ac2O, 10.6 g, 103 mmol) was added slowly and the reaction mixture was stirred at room temperature for 1 hour. Subsequently, the mixture was heated to 60 °C and tert-butyl nitrite (t-BuONO, 10.2 g, 98.3 mmol) was added. The resulting mixture was continued to be stirred at 60 °C for 4 hours. After completion of the reaction, it was cooled to room temperature, the reaction was quenched with saturated aqueous sodium bicarbonate (NaHCO3) and extracted with ethyl acetate (EtOAc). The organic layer was separated, dried over anhydrous sodium sulfate and concentrated to give the crude product. The crude product was purified by silica gel column chromatography (eluent: petroleum ether/ethyl acetate=100:0 to 10:1) to afford methyl 5-bromo-1H-indazole-7-carboxylate (19-S4, 8.0 g, 70.5% yield) as a yellow solid. lc-MS (ESI) m/z: 255 (M+H).

References

[1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 11, p. 2578 - 2581
[2] Patent: WO2018/160889, 2018, A1. Location in patent: Page/Page column 474; 475
[3] Patent: WO2015/157093, 2015, A1. Location in patent: Paragraph 0394
[4] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 3, p. 1156 - 1162
[5] Patent: WO2008/65508, 2008, A1

5-BROMO-7-INDAZOLECARBOXYLIC ACID METHYL ESTERSupplier

Shanghai YuanQi Biotechnology Co., Ltd. Gold
Tel
+86-2332782371 +86-18120098618
Email
sales@adobechem.com
Shanghai Haozhu Pharmaceutical Technology Co. , Ltd. Gold
Tel
18912729622
Email
66161984@qq.com
Accela ChemBio Co.,Ltd.
Tel
021-50795510 4000665055
Email
sales@accelachem.com
ZEROSCHEM.CO.,LTD.
Tel
10-61256048 13810278579
Email
sales@zeroschem.com
Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
18270980682
Email
mlcheng@sunwaypharm.cn